Novo Nordisk said on Tuesday is has contracted Aspen Pharmacare to produce human insulin on its behalf in South Africa for export to African countries through a low-cost government tender system.
Novo Nordisk, a pharmaceutical company, experienced a decline in its stock prices following a report by financial news agency MarketWire.

Why Novo Nordisk Stock Dipped Today

05:25pm, Monday, 18'th Sep 2023
A media report highlighted the struggles the company has faced in manufacturing its highly popular drug. That drug, Wegovy, is flying off pharmacy shelves thanks to its weight-loss qualities.
Novo Nordisk's shares fell on Monday after financial news agency MarketWire reported that U.S. drug regulators had recently issued a report detailing quality control lapses at the group's Clayton, Nor
Eight high-flying stocks have conducted forward-stock splits over the past two years, with another on the way later this week. Some of Wall Street's most prominent billionaire fund managers have gravi
Ozempic-maker Novo Nordisk is Europe's second-largest company by market capitalization. It's also boosting Denmark's economy all on its own.
Ozempic is Novo Nordisk's crown jewel, and it's wildly successful so far. Researchers just found that it could also be useful for treating type 1 diabetes.
It's easy to get scared by arguments in favor of selling a stock. Novo Nordisk stock is flying to new heights thanks to its sales of Ozempic.
Medtronic delivers a solid dividend as well as strong returns. CRISPR Therapeutics could soon have its first approved therapy on the market.
Novo Nordisk (NVO) conducts a two-for-one stock split. While this is already in effect at the stock exchange in Denmark, the ADRs listed on the NYSE will be split in the same ratio by next week.
The controlling shareholder in drugmaker Novo Nordisk on Thursday announced a major investment in a new energy transition fund as it expands its portfolio beyond health.
Novo Nordisk has been a meaningful contributor to growth of the Danish economy lately. The company's financial results are excellent thanks to a portfolio of diabetes and obesity drugs.
Novo Nordisk plans to conduct a 2-for-1 stock split on Sept. 20, increasing share count and reducing share price.
After rallying 17% higher in 2023, volatility now rules the S&P 500. Sharp swings higher and lower has the popular benchmark sitting below its August highs.
One of today's top trending names is Novo Nordisk (NYSE: NVO ). The Danish pharmaceutical producer has seen its international profile grow this year due to the success of Ozempic.
Click to get the best stock tips daily for free!

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE